DR
Dhamodharan Ramasamy
Sri Balaji Vidyapeeth University, National Institute of Epidemiology, Pondicherry University, Avanzbio Pvt Ltd
Employment
-
Sri Balaji Vidyapeeth University Associate Professor2022 - Present
-
Sri Balaji Vidyapeeth University Assistant Professor2022 - 2025
-
National Institute of Epidemiology Project Consultant2021 - 2022
-
Avanzbio Pvt Ltd Principal Scientist2019 - 2021
-
Seoul National University Postdoctoral Researcher2016 - 2019
-
Aix-Marseille Université Faculté de Medecine Postdoctoral Research Fellow2012 - 2014
Education
-
Pondicherry University PhD2003 - 2009
Projects & Funding
Projects & funding information is unavailable.
Publications (42)
- In-vitro evaluation of Cefiderocol and Ceftazidime/Avibactam against MDR and XDR gram-negative pathogens from clinical isolates, with whole genome sequencing-based analysis of Antimicrobial Resistance Genes in Cefiderocol-resistant Escherichia coli Save
- Comparative and phylogenomic analysis of Eikenella genus suggest taxonomic reclassification of Eikenella corrodens strain KCOM 3110 as novel species and reveals unique CE1 carbohydrate-active enzyme family Save
- Unveiling Hidden Microbe: A Systematic Review on the Role of Candidatus Saccharibacteria in Oral Microbiome Dynamics and Disease Save
- Comparative and pan-genome analysis of the complete genomes of the periodontal pathogen Tannerella forsythia reveals unique tetracycline resistance protein Q and GT22 carbohydrate-active enzyme family in strain 92A2 Save
- Comparative and phylogenomic analysis of Chlamydia pneumoniae reveals unique carbohydrate active enzyme family (GT5) among respiratory isolates Save
- Comparative genome analysis of human pathogen Parvimonas micra revealed strain JM503A as potential novel species in the genus Parvimonas and high intra-species functional diversity Save
- Whole-genome sequencing and comparative genome analysis of three multidrug-resistant clinical uropathogenic Escherichia coli isolates from India Save
- Reviewer Save
- Reviewer Save
- In silico analysis of the key molecules of SARS-CoV-2: ACE2 and TMPRSS2 in head and neck cancer Save